etizolam has been researched along with carbamazepine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Aoshima, T; Fukasawa, T; Inoue, Y; Kondo, S; Otani, K; Suzuki, A; Tateishi, T; Yasui-Furukori, N | 1 |
1 trial(s) available for etizolam and carbamazepine
Article | Year |
---|---|
Induction of the metabolism of etizolam by carbamazepine in humans.
Topics: Administration, Oral; Adult; Analgesics, Non-Narcotic; Area Under Curve; Carbamazepine; Chromatography, High Pressure Liquid; Cross-Over Studies; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Half-Life; Humans; Male; Metabolic Clearance Rate; Tranquilizing Agents | 2005 |
2 other study(ies) available for etizolam and carbamazepine
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |